ChemBio Discovery

Edison, United States Founded: 2015 • Age: 11 yrs
Offers computational modeling and consultancy services for small molecules and biologics.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About ChemBio Discovery

ChemBio Discovery is a company based in Edison (United States) founded in 2015 by Santosh Khedkar. It operates as a B2B. ChemBio Discovery operates in a competitive market with competitors including Aganitha, Cellumen, PointCross, IOTA Pharma and Emergentec, among others.

  • Headquarter Edison, United States
  • Founders Santosh Khedkar
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Education, Research & Associations Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ChemBio Discovery

Premium access

Detailed funding history for ChemBio Discovery

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ChemBio Discovery

Investments
Premium access

Investment portfolio details for ChemBio Discovery

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ChemBio Discovery

Premium access

Detailed financials for ChemBio Discovery

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Chembio Discovery Comparisons

ChemBio Discovery Primary company
Description
Offers computational modeling and consultancy services for s...
Location
Edison, United States
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ChemBio Discovery

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ChemBio Discovery

ChemBio Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aganitha, Cellumen, PointCross, IOTA Pharma and Emergentec, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of AI-powered drug discovery and development solutions
Locked Locked Locked
Systems biology solutions for drug safety and efficacy are provided.
Locked Locked Locked
Big data platform & desktop software for preclinical & clinical research & regulatory applications
Locked Locked Locked
Offers fragment-based drug discovery products and services.
Locked Locked Locked
Computational solutions and consulting for better decision making in biomarker, target and drug development.
Locked Locked Locked
Offers AI and machine learning for in-silico drug discovery and bioinformatics services.
Premium access

Detailed competitors of ChemBio Discovery

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Chembio Discovery

Premium access

Complete news archive for ChemBio Discovery

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ChemBio Discovery

ChemBio Discovery was founded in 2015.

ChemBio Discovery is headquartered in Edison, United States. It is registered at Edison, New Jersey, United States.

ChemBio Discovery offers computational modeling and consultancy services for small molecules and biologics through providing healthcare solutions, advancing biotech innovations, drug discovery, and computational modeling. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

ChemBio Discovery's top competitors include Aganitha, Cellumen and PointCross.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available